COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva announces FDA's removal of recommended pause on Chikungunya Vaccine IXCHIQ® in elderly individuals and updates to the Prescribing Information, following EMA's recommendation. Updates reflect Serious Adverse Events and expanded Warnings and Precaution section -
COMMUNIQUÉ DE PRESSE
9 Months: Economic weakness and geopolitical environment pose temporary challenges // Comprehensive pipeline underpins strong positioning in the SAP market // Revised forecast confirmed
All for One Group SE faces temporary challenges in weak economy and geopolitical environment with revised forecast confirmation. 9-month figures show slight revenue growth and focus on SAP market positioning -
-
-
-
COMMUNIQUÉ DE PRESSE
Brockhaus Technologies AG: Publication of the audited annual financial statements; revenue increases in 2024 by +9.5% to €204 million and adjusted EBITDA by +4.5% to €65 million.
Brockhaus Technologies AG reports +9.5% revenue growth in 2024 to €204 million and +4.5% increase in adjusted EBITDA to €65 million. Company outlook for 2025 revealed -
COMMUNIQUÉ DE PRESSE
SMA Group presents final figures for the first half of 2025
SMA Group presents final figures for the first half of 2025, with sales at €684.9 million and EBITDA at €55.1 million. Home Solutions affected by declining demand. Large Scale & Project Solutions report increased sales and earnings -
-
